M

Multicell Technologies Inc
OTC:MCET

Watchlist Manager
Multicell Technologies Inc
OTC:MCET
Watchlist
Price: 0.0001 USD Market Closed
Market Cap: 5k USD

Operating Margin
Multicell Technologies Inc

-33.2%
Current
-2 423%
Average
-5%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-33.2%
=
Operating Profit
-267.6k
/
Revenue
805.2k

Operating Margin Across Competitors

Multicell Technologies Inc
Glance View

Market Cap
5k USD
Industry
Biotechnology

MultiCell Technologies, Inc. operates as a clinical-stage biopharmaceutical company. The company is headquartered in Woonsocket, Rhode Island. The firm and its subsidiaries are developing therapeutics and discovery tools for the treatment of neurological disorders, hepatic disease, cancer and interventional cardiology, and peripheral vessel applications. The firm's portfolio of lead drug candidates is in various stages of discovery optimization, and preclinical and clinical development, and includes MCT-125, MCT-465, MCT-475 and MCT-485. MCT-125 is a Phase II therapeutic candidate for the treatment of primary multiple sclerosis-related fatigue. MCT-465 is a preclinical synthetic double-stranded ribonucleic acid (dsRNA) therapeutic candidate and potent immune enhancer for the treatment of solid tumor cancers. MCT-475 is a discovery-stage antibody therapeutic candidate used in combination with dsRNA for the treatment of solid tumor cancers. MCT-485 is a discovery-stage dsRNA therapeutic candidate for the treatment of certain cancers.

MCET Intrinsic Value
Not Available
M
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-33.2%
=
Operating Profit
-267.6k
/
Revenue
805.2k
What is the Operating Margin of Multicell Technologies Inc?

Based on Multicell Technologies Inc's most recent financial statements, the company has Operating Margin of -33.2%.

Back to Top